Literature DB >> 18791329

Severe eosinophilia as a manifestation of acute graft-versus-host disease.

Vikram R Paralkar1, Ami Goradia, Selina M Luger, Alison W Loren.   

Abstract

Significant peripheral eosinophilia in association with acute graft-versus-host disease (GVHD) is rare. Here we report a case of eosinophilia in a 30-year-old woman with relapsed acute myelogenous leukemia after an allogeneic bone marrow transplant who was treated with donor lymphocyte infusion (DLI). A month after the DLI, she developed a pruritic erythematous rash, hepatic enzyme elevations and eosinophilia that peaked at 23,300 cells/mm(3). A diagnosis of acute GVHD was made and the patient was treated with corticosteroids with a resolution of all of the aforementioned findings. The authors suggest that eosinophilia in a bone marrow transplantation patient should raise suspicion of GVHD. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18791329     DOI: 10.1159/000155224

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  2 in total

1.  Drugs as a Frequent Cause of Acute Rash in Patients after CD34+-Selected Peripheral Blood Stem Cell Transplantation.

Authors:  Skylar Klager; Mario E Lacouture; Margaret Hannum; Sean M Devlin; Molly Maloy; Melissa Pulitzer; Ann A Jakubowski; Alina Markova
Journal:  Biol Blood Marrow Transplant       Date:  2019-07-12       Impact factor: 5.742

2.  Eosinophils in the blood of hematopoietic stem cell transplanted patients are activated and have different molecular marker profiles in acute and chronic graft-versus-host disease.

Authors:  Julia Cromvik; Marianne Johnsson; Krista Vaht; Jan-Erik Johansson; Christine Wennerås
Journal:  Immun Inflamm Dis       Date:  2014-07-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.